Daré Bioscience Reports Third Quarter 2023 Financial Results and Provides Company Update
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the quarter ended September 30, 2023 and provided a company update.
- ET
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the quarter ended September 30, 2023 and provided a company update. - XACIATO™ provides a new therapeutic option for the millions of women suffering from bacterial vaginosis in the U.S.
- Financial Highlights for the Quarter ended September 30, 2023
Cash and cash equivalents: $13.8 million at September 30, 2023. - Daré will host a conference call and live webcast today, November 9, 2023, at 4:30 p.m. Eastern Time to review financial results for the quarter ended September 30, 2023 and to provide a company update.